Search Results - "Mohr, Raphael U."

Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy by Gonzalez-Carmona, Maria A., Möhring, Christian, Mahn, Robert, Zhou, Taotao, Bartels, Alexandra, Sadeghlar, Farsaneh, Bolch, Maximilian, Vogt, Annabelle, Kaczmarek, Dominik J., Heling, Dominik J., Dold, Leona, Nattermann, Jacob, Branchi, Vittorio, Matthaei, Hanno, Manekeller, Steffen, Kalff, Jörg C., Strassburg, Christian P., Mohr, Raphael U., Weismüller, Tobias J.

“…Prognosis of patients with advanced extrahepatic cholangiocarcinoma (eCCA) is poor. The current standard first-line treatment is systemic chemotherapy (CT)…”
Get full text

First Line and Second Line Chemotherapy in Advanced Cholangiocarcinoma and Impact of Dose Reduction of Chemotherapy: A Retrospective Analysis by Möhring, Christian, Feder, Jan, Mohr, Raphael U, Sadeghlar, Farsaneh, Bartels, Alexandra, Mahn, Robert, Zhou, Taotao, Marinova, Milka, Feldmann, Georg, Brossart, Peter, von Websky, Martin, Matthaei, Hanno, Manekeller, Steffen, Glowka, Tim, Kalff, Jörg C, Weismüller, Tobias J, Strassburg, Christian P, Gonzalez-Carmona, Maria A

“…Prognosis of patients with irresectable cholangiocarcinoma is still poor. The ABC-02 trial established the current first line (1L) standard systemic…”
Get full text

Combined photodynamic therapy with systemic chemotherapy for unresectable cholangiocarcinoma by Gonzalez‐Carmona, Maria Angeles, Bolch, Maximilian, Jansen, Christian, Vogt, Annabelle, Sampels, Matthias, Mohr, Raphael U., van Beekum, Katrin, Mahn, Robert, Praktiknjo, Michael, Nattermann, Jacob, Trebicka, Jonel, Branchi, Vittorio, Matthaei, Hanno, Manekeller, Steffen, Kalff, Jörg C., Strassburg, Christian P., Weismüller, Tobias J.

“…Summary Background Chemotherapy with gemcitabine and cisplatin is the current standard for patients with unresectable cholangiocarcinoma. Local photodynamic…”
Get full text

Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells by Sadeghlar, Farsaneh, Vogt, Annabelle, Mohr, Raphael U., Mahn, Robert, van Beekum, Katrin, Kornek, Miroslaw, Weismüller, Tobias J., Branchi, Vittorio, Matthaei, Hanno, Toma, Marieta, Schmidt-Wolf, I. G. H., Kalff, Jörg C., Strassburg, Christian P., González-Carmona, Maria A.

“…Introduction Gastrointestinal (GI) malignancies, such as cholangiocarcinoma, pancreatic carcinoma, and metastatic colorectal carcinoma, have a poor prognosis…”
Get full text

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study by Qin, Shukui, Chan, Stephen L, Bai, Yuxian, Chen, Zhendong, Jia, Weidong, Jin, Yongdong, Guo, Yabing, Hu, Xiaohua, Meng, Zhiqiang, Liang, Jun, Cheng, Ying, Xiong, Jianping, Ren, Hong, Chen, Yajin, Zeng, Yong, Sultanbaev, Alexander, Pazgan-Simon, Monika, Melisi, Davide, Ponomarenko, Dmitriy, Sinielnikov, Ivan, Yang, Tsai-Sheng, Liang, Xiao, Chen, Chunxia, Wang, Linna, Cheng, Ann-Lii, Vogel, Arndt, Qin, Shukui, Chan, Stephen L, Vogel, Arndt, Gu, Shanzhi, Bai, Yuxian, Ren, Zhenggang, Lin, Xiaoyan, Chen, Zhendong, Hu, Xiaohua, Meng, Zhiqiang, Liang, Jun, Cheng, Ying, Xiong, Jianping, Ren, Hong, Yang, Fang, Zeng, Yong, Sultanbaev, Alexander, Pisetska, Margaryta, Melisi, Davide, Ponomarenko, Dmitriy, Osypchuk, Yurii, Sinielnikov, Ivan, Yang, Tsai-Sheng, Liang, Xiao, Chen, Chunxia, Zhang, Mingxiang, Xu, Li, Li, Da, Ying, Jierer, Zhang, Jingdong, Zhang, Tao, He, Yifu, Jiang, Da, Xing, Baocai, Zhang, Baihong, Wang, Dong, Zhai, Xiaofeng, Liang, Houjie, Cybulska-Stopa, Bozena, Dvorkin, Mikhail, Stroyakovskiy, Daniil, Yen, Chia-Jui, Su, Wei-Wen, Chen, Yen-Hao, Bondarenko, Igor, Fang, Weijia, Gomez-Martin, Carlos, Ryu, Min-Hee, Kim, Han-Sang, Kim, Jee-Hyun, Orlova, Rashida, Fadeeva, Natalia, Makarova, Yulia, Hung, Chao-Hung, Neffa, Maryna, Vynnychenko, Oleksandr, Burgoyne, Adam, Hao, Chunyi, Mohr, Raphael U, Diaz-Beveridge, Roberto, Feliu-Batlle, Jaime, Antonuzzo, Lorenzo, Scartozzi, Mario, Ahn, Mi Sun, Oh, Sung-Yong, Orlov, Sergey, Oksuzoglu, Berna, Rau, Kun-Ming, Krechkovskyi, Oleksandr, Yareshko, Vladimir, Xiong, Henry, Lee, Fa-Chyi, Jiang, Yixing, Verset, Gontran

“…Immunotherapy with immune checkpoint inhibitors combined with an anti-angiogenic tyrosine-kinase inhibitor (TKI) has been shown to improve overall survival…”
Get full text